PHGE

BiomX Inc. (PHGE) Risks & Opportunities Analysis (2026)

Invetso Score: 2.8/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 2.4 (Weak)

Current ratio of 0.24 versus better-capitalized peers signals acute liquidity pressure, which can constrain operating flexibility and financing terms over the next 1–5 years.

Interest coverage of -27.3x versus profitable peers indicates earnings are not supporting obligations, increasing refinancing and dilution risk if capital markets tighten.

Days sales outstanding of 360 versus faster-collecting peers implies cash is trapped in receivables, worsening working-capital strain and limiting reinvestment capacity.

Cash conversion cycle of 233 days versus more efficient peers suggests structurally slower cash generation, which can amplify downside in a weak demand or funding environment.

Opportunities

Score:

Net debt to EBITDA of -0.12x versus levered peers indicates low net leverage, which can preserve optionality if operating performance stabilizes and funding access remains open.

Debt-to-equity of 0.31 versus more levered peers suggests balance-sheet claims are relatively contained, reducing the probability that creditors dominate future capital allocation.

If receivable collection improves toward peer norms, the large working-capital drag could release cash and partially offset liquidity pressure over the medium term.

Overall Score

Score:

PHGE’s forward positioning is constrained primarily by severe liquidity and cash-conversion weakness versus peers, while modest balance-sheet leverage provides only limited offset.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on BiomX Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →